PL
VRTX icon

Parkwood LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Parkwood LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,324
Closed -$201K – 258
2017
Q3 		$201K Sell
1,324
-1,163
-47% -$175K 0.03% 208
2017
Q2 		$320K Buy
+2,487
New +$299K 0.05% 275
2015
Q3 		– Sell
-5,427
Closed -$670K – 563
2015
Q2 		$670K Hold
5,427
– – 0.09% 140
2015
Q1 		$640K Hold
5,427
– – 0.08% 149
2014
Q4 		$645K Buy
5,427
+2,048
+61% +$231K 0.09% 127
2014
Q3 		$379K Buy
+3,379
New +$322K 0.08% 180
2014
Q1 		– Sell
-1,303
Closed -$97K – 430
2013
Q4 		$97K Buy
+1,303
New +$90.7K 0.02% 501

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return